- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Tyco to scoop up C.R. Bard
Another medical device manufacturer may soon join Tyco International. The multinational company, which has made a habit of gobbling up others, has signed a definitive agreement to buy C.R. Bard in a stock swap valued at about $3.2 billion, including the
Another medical device manufacturer may soon join Tyco International. The multinational company, which has made a habit of gobbling up others, has signed a definitive agreement to buy C.R. Bard in a stock swap valued at about $3.2 billion, including the assumption of net debt, based on Tyco’s May 29 closing share price of $57. Bard shareholders will receive Tyco shares valued (just prior to the Bard shareholder vote) at $60 for each share of Bard, subject to an adjustment should Tyco stock trade below $50 during a measurement period. Bard, which had 2000 revenues of $1.1 billion, is a leading medical devices manufacturer of products used for vascular, urological, and oncological diagnosis and intervention as well as surgical specialties. Tyco’s holdings include US Surgical and Mallinckrodt.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
